Is anti-platelet therapy interruption a real clinical issue? Its implications in dentistry and particularly in periodontics

Is anti-platelet therapy interruption a real clinical issue? Its implications in dentistry and particularly in periodontics

Blog Article

The use of anti-platelet therapy has reduced the mortality and morbidity of cardiovascular disease remarkably.A considerable number of patients presenting before a dentist or periodontist give a history of anti-platelet therapy.A clinical dilemma whether to discontinue the anti-platelet therapy or continue the same always confronts the practitioner.Diverse opinions exist regarding the management of such patients.While one group of researchers advise continuation of anti-platelet therapy rather than invite remote, but possible, thromboembolic events, another group encourages discontinuation for Boning Knives variable periods.

This Glass Bottle study aims at reviewing the current rationale of anti-platelet therapy and the various options available to a clinician, with regard to the management of a patient under anti-platelet therapy.Current recommendations and consensus favour no discontinuation of anti-platelet therapy.This recommendation, however, comes with a rider to use caution and consider other mitigating factors as well.With a large number of patients giving a history of anti-platelet therapy, the topic is of interest and helps a clinician to arrive at a decision.